Altered expression of transforming growth factor-beta in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neurology

• Publication date

  1995-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1212/WNL.45.8.1561PMID 7543987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No linkage to chromosome 14 in Swedish Alzheimer's disease families

  1993cited by this paper
• Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

  1993cited by this paper
• Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

  1993cited by this paper
• Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity.

  1993cited by this paper
• Neurosurgical horizons in Parkinson's disease

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes.

  1993cited by this paper
• Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-->glycine).

  1993cited by this paper
• Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

  1993cited by this paper
• Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.

  1993cited by this paper
• Isoform‐Specific Effects of Transforming Growth Factors‐β on Degeneration of Primary Neuronal Cultures Induced by Cytotoxic Hypoxia or Glutamate

  1993cited by this paper
• Agonist Regulation of Gene Expression of Adrenergic Receptors and G Proteins

  1993cited by this paper
• Retinoic acid, local cell-cell interactions, and pattern formation in vertebrate limbs.

  1992cited by this paper
• Positional cloning: Let's not call it reverse anymore

  1992cited by this paper
• Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain.

  1992cited by this paper
• Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14

  1992cited by this paper
• Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor

  1992cited by this paper
• How accurately can Parkinson's disease be diagnosed?

  1992cited by this paper
• Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation

  1992cited by this paper
• Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury.

  1992cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

  1992cited by this paper
• Transforming growth factor beta has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor.

  1992cited by this paper
• Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses.

  1992cited by this paper
• Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.

  1991cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

  1991cited by this paper
• Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

  1991cited by this paper
• Cell type-specific lectin staining of the tracheobronchial epithelium of the rat: quantitative studies with Griffonia simplicifolia I isolectin B4.

  1991cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Neuritic pathology and dementia in alzheimer's disease

  1991cited by this paper
• Entorhinal cortex pathology in Alzheimer's disease

  1991cited by this paper
• Screening for the beta-amyloid precursor protein mutation (APP717: Val----Ile) in extended pedigrees with early onset Alzheimer's disease.

  1991cited by this paper
• Localization and actions of transforming growth factor-beta s in the embryonic nervous system.

  1991cited by this paper
• EC look to animal patents

  1991cited by this paper
• Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system.

  1991cited by this paper
• Abnormal brain spectrin immunoreactivity in sprouting neurons in Alzheimer disease.

  1991cited by this paper
• Peptide Growth Factors and Their Receptors I

  1990cited by this paper
• Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms.

  1990cited by this paper
• Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease.

  1990cited by this paper
• Antibodies to transforming growth factor-beta 2 peptides: specific detection of TGF-beta 2 in immunoassays.

  1990cited by this paper
• Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms.

  1990cited by this paper
• Antibodies to transforming growth factor-β2 peptides: Specific detection of TGF-β2 in immunoassays

  1990cited by this paper
• Sandwich Enzyme-Linked Immunosorbent Assays (Selisas) Quantitate and Distinguish Two Forms of Transforming Growth Factor-Beta (TGF-β1 and TGF-β2) in Complex Biological Fluids

  1989cited by this paper
• Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes

  1989cited by this paper
• Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids.

  1989cited by this paper
• Transforming growth factor type beta 3 maps to human chromosome 14, region q23-q24.

  1988cited by this paper
• Antibodies to peptide determinants in transforming growth factor beta and their applications.

  1988cited by this paper
• Familial alzheimer's disease in american descendants of the volga germans: Probable genetic founder effect

  1988cited by this paper
• Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

  1988cited by this paper
• Epitopes that span the tau molecule are shared with paired helical filaments.

  1988cited by this paper
• To treat early or to treat late?

  1987cited by this paper
• Aminergic systems in Alzheimer's disease and Parkinson's disease

  1987cited by this paper
• Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.

  1987cited by this paper
• A postmortem study of amino acid neurotransmitters in Alzheimer's disease

  1986cited by this paper
• Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.

  1986cited by this paper
• Perforant pathway changes and the memory impairment of Alzheimer's disease

  1986cited by this paper
• Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7

  1986cited by this paper
• Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

  1986cited by this paper
• Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

  1986cited by this paper
• Development of a chemically defined serum- and protein-free medium for growth of human peripheral lymphocytes.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Amygdaloid changes in aging and dementia.

  1980cited by this paper
• Imitating gestures. A quantitative approach to ideomotor apraxia.

  1980cited by this paper
• Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

  1977cited by this paper
• PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY

  1974cited by this paper

• A high cholesterol diet accelerates Alzheimer's progression by promoting fibrotic damage in rats

  2025cites this paper
• Inactivation of BACE2 stimulates release of endothelin-1 from human brain microvascular endothelial cells

  2025cites this paper
• A review of the TGF-β1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants.

  2025cites this paper
• Inflammatory Bridges: Interconnections Between Alzheimer’s Disease and Bone Health

  2025cites this paper
• Mediterranean Diet Modulation of Neuroinflammation-Related Genes in Elderly Adults at High Cardiovascular Risk

  2024cites this paper
• What Can We Learn About Alzheimer's Disease from People with Down Syndrome?

  2024cites this paper
• Fluid biomarkers in cerebral amyloid angiopathy

  2024cites this paper
• Genetic Reduction of Insulin Signaling Mitigates Amyloid-β Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain

  2023cites this paper
• The relationship between TGF-β1 and cognitive function in the brain.

  2023cites this paper
• Cellular Localization and Distribution of TGF-β1, GDNF and PDGF-BB in the Adult Primate Central Nervous System

  2023cites this paper
• The contribution of inflammation to Alzheimer's disease in Down syndrome

  2022cites this paper
• Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice

  2022cites this paper
• Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer's Disease.

  2021cites this paper
• Systematic review of human post‐mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease

  2021cites this paper
• Identification of Methylated Gene Biomarkers in Patients with Alzheimer's Disease Based on Machine Learning

  2020cites this paper
• Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin

  2019cites this paper
• A functional variant in the miR‐142 promoter modulating its expression and conferring risk of Alzheimer disease

  2019cites this paper
• Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease

  2019cites this paper
• TGF-β Signaling in Cellular Senescence and Aging-Related Pathology

  2019cites this paper
• Human Mutation

  2019cites this paper
• Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia

  2018cites this paper
• Inhibition of Serine Palmitoyltransferase by a Small Organic Molecule Promotes Neuronal Survival after Astrocyte Amyloid Beta 1-42 Injury.

  2018cites this paper
• Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword

  2018cites this paper
• N-3 Polyunsaturated Fatty Acids and Neuroinflammation in Alzheimer's Disease

  2017cites this paper
• United States Patent

  2017cites this paper
• Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review

  2017cites this paper
• A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors.

  2017cites this paper
• Potential importance of B cells in aging and aging-associated neurodegenerative diseases

  2017cites this paper
• Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.

  2017cites this paper
• Effect of Environmental Extremely Low-Frequency Electromagnetic Fields Exposure on Inflammatory Mediators and Serotonin Metabolism in a Human Neuroblastoma Cell Line.

  2016cites this paper
• Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer’s Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load

  2016cites this paper
• Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice

  2016cites this paper
• Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease

  2016cites this paper
• Morphogens and blood-brain barrier function in health and disease

  2016influential citation
• Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.

  2016cites this paper
• Interleukin17A Promotes Postoperative Cognitive Dysfunction by Triggering β-Amyloid Accumulation via the Transforming Growth Factor-β (TGFβ)/Smad Signaling Pathway

  2015cites this paper
• Different expression patterns of growth factors in rat fetuses with spina bifida aperta after in utero mesenchymal stromal cell transplantation.

  2014cites this paper
• A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity

  2014cites this paper
• Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.

  2014cites this paper
• Alzheimer’s Disease and Inflammation

  2014cites this paper
• Identification and analysis of Rab8 mutants: genetic enhancers of a Drosophila model of Frontotemporal Dementia

  2013cites this paper
• Inflammatory process in Alzheimer's Disease

  2013cites this paper
• Initiating Complement-Dependent Synaptic Refinement: Mechanisms of Neuronal C1q Regulation

  2013cites this paper
• Neuroinflammation and Copper in Alzheimer's Disease

  2013cites this paper
• Perspectives Series : Cytokines and the Brain Neural-immune Interactions in Health and Disease

  2013cites this paper
• TGF-β in Human Disease

  2013cites this paper
• TGF-β in Brain Disorders

  2013cites this paper
• Immunohistochemical and ultrastructural evaluation of the pathology and aetiopathogenesis of keloid formation.

  2013cites this paper
• Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer’s disease

  2013cites this paper
• Plasma and Cerebrospinal Fluid-Based Protein Biomarkers for Motor Neuron Disease

  2012cites this paper
• Potential Immunotargets for Alzheimer's Disease Treatment Strategies

  2012cites this paper
• Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease

  2012cites this paper
• Alzheimer's disease: recent advances and future perspectives.

  2012cites this paper
• The Effects of Apolipoproteins E3 and E4 on the Transforming Growth Factor-β System in Targeted Replacement Mice

  2012cites this paper
• MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilins.

  2012cites this paper
• Vascular damage in the central nervous system: a multifaceted role for vascular-derived TGF-β

  2011cites this paper
• More than being protective: functional roles for TGF-β/activin signaling pathways at central synapses.

  2011cites this paper
• Angiogenic Mediators and the Pathogenesis of Alzheimer’s Disease

  2010cites this paper
• TAG-1 is an inhibitor of TGFbeta2-induced neuronal death via amyloid beta precursor protein.

  2010cites this paper
• TGF-β2 alters the characteristics of the neuromuscular junction by regulating presynaptic quantal size

  2010cites this paper
• Transforming Growth Factor β2 Level is Elevated in Neurons of Alzheimer's Disease Brains

  2010cites this paper
• Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins

  2010cites this paper
• Tau hyperphosphorylation affects Smad 2/3 translocation.

  2009cites this paper
• Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

  2009cites this paper
• Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy

  2009cites this paper
• TGF beta2-induced changes in LRP-1/T beta R-V and the impact on lysosomal A beta uptake and neurotoxicity.

  2008cites this paper
• TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury.

  2008cites this paper
• TGF-β1 and TGF-β2 expression after traumatic human spinal cord injury

  2008cites this paper
• Transforming Growth Factor-β in Brain Functions and Dysfunctions

  2008cites this paper
• TGF-β1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis

  2008cites this paper
• Neurofibrillary Tangles May Interfere With Smad 2/3 Signaling in Neurons

  2007cites this paper
• Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.

  2007cites this paper
• Transforming growth factor-β

  2007cites this paper
• TGFβ Receptor I Conditional Knockout Mice Develop Spontaneous Squamous Cell Carcinoma

  2007cites this paper
• Common pathological processes in Alzheimer disease and type 2 diabetes: a review.

  2007cites this paper
• Systemic and acquired immune responses in Alzheimer's disease.

  2007cites this paper
• Transforming growth factor beta2 autocrinally mediates neuronal cell death induced by amyloid-beta.

  2006cites this paper
• Neurodegenerative Diseases: Mechanisms and Therapies

  2006influential citation
• 6 Transforming Growth Factor-b si n the Brain

  2006cites this paper
• Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.

  2006cites this paper
• Transforming Growth Factor-&bgr;1 Is a Negative Modulator of Adult Neurogenesis

  2006cites this paper
• Adrenalectomy promotes a permanent decrease of plasma corticoid levels and a transient increase of apoptosis and the expression of Transforming Growth Factor β1 (TGF-β1) in hippocampus: effect of a TGF-β1 oligo-antisense

  2006cites this paper
• Transforming growth factor β2 autocrinally mediates neuronal cell death induced by amyloid‐β

  2006influential citation
• Transforming growth factor-β signalling in brain disorders

  2006cites this paper
• Transforming Growth Factor-βs in the Brain

  2006cites this paper
• The TGF-β1/Upstream Stimulatory Factor-Regulated PAI-1 Gene: Potential Involvement and a Therapeutic Target in Alzheimer's Disease

  2006cites this paper
• Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study.

  2006cites this paper
• Potential Inflammatory biomarkers in Alzheimer's disease

  2006cites this paper
• Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's.

  2006cites this paper
• Transforming growth factor-beta signalling in brain disorders.

  2006cites this paper
• Cytokines and Neurodegeneration

  2005cites this paper
• Transport of transforming growth factor-beta 2 across the blood-brain barrier.

  2005cites this paper
• Transcriptome differences between the frontal cortex and hippocampus of wild-type and humanized presenilin-1 transgenic mice.

  2005cites this paper
• Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein.

  2005cites this paper
• The immunopharmacological properties of transforming growth factor beta.

  2005cites this paper
• Sp1 and Smad transcription factors co-operate to mediate TGF-β-dependent activation of amyloid-β precursor protein gene transcription

  2004cites this paper
• TGF-β1 Represses Activation and Resultant Death of Microglia via Inhibition of Phosphatidylinositol 3-Kinase Activity1

  2004cites this paper
• Cytokines in neuroinflammation and Alzheimer's disease.

  2004cites this paper
• Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription.

  2004cites this paper
• Role of LRP in TGFβ2‐mediated neuronal uptake of Aβ and effects on memory

  2004cites this paper